CHANGJIU HLDGS (6959.HK)

HKD 6.1

(1.67%)

EBITDA Summary of CHANGJIU HLDGS

  • CHANGJIU HLDGS's latest annual EBITDA in 2023 was 129.5 Million CNY , down -10.52% from previous year.
  • CHANGJIU HLDGS's latest quarterly EBITDA in 2024 Q2 was 80.06 Million HKD , up 111.13% from previous quarter.
  • CHANGJIU HLDGS reported an annual EBITDA of 137.6 Million CNY in 2022, up 30.65% from previous year.
  • CHANGJIU HLDGS reported an annual EBITDA of 101.13 Million CNY in 2021, down -6.41% from previous year.
  • CHANGJIU HLDGS reported a quarterly EBITDA of 40.48 Million HKD for 2024 Q1, down -43.5% from previous quarter.
  • CHANGJIU HLDGS reported a quarterly EBITDA of 73.08 Million HKD for 2023 Q4, up 55.14% from previous quarter.

Annual EBITDA Chart of CHANGJIU HLDGS (2023 - 2020)

Historical Annual EBITDA of CHANGJIU HLDGS (2023 - 2020)

Year EBITDA EBITDA Growth
2023 129.5 Million CNY -10.52%
2022 137.6 Million CNY 30.65%
2021 101.13 Million CNY -6.41%
2020 115.96 Million CNY 0.0%

Peer EBITDA Comparison of CHANGJIU HLDGS

Name EBITDA EBITDA Difference
Founder Holdings Limited 78.44 Million HKD -65.095%
Tradelink Electronic Commerce Limited 87.11 Million HKD -48.663%
Inspur International Limited 361.65 Million HKD 64.191%
BC Technology Group Limited -185.82 Million HKD 169.692%
Vobile Group Limited 275.14 Million HKD 52.933%
Finsoft Financial Investment Holdings Limited -18.95 Million HKD 783.136%
eBroker Group Limited 5.59 Million HKD -2216.258%
Yu Tak International Holdings Limited -11.95 Million HKD 1183.517%
Global Link Communications Holdings Limited -57.99 Thousand HKD 223383.16%
China Netcom Technology Holdings Limited -10.38 Million HKD 1346.77%
China Youzan Limited 78.03 Million HKD -65.947%
Aurum Pacific (China) Group Limited -10.63 Million HKD 1317.696%
Sinopharm Tech Holdings Limited -1.01 Million HKD 12858.83%